Clinical Trials
69 trialsNANORAD2
University Hospital, Grenoble
Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases
Tongji Hospital
CBC
Second Affiliated Hospital of Nanchang University
ImPRESS
Oslo University Hospital
OptimalTTF-2
University of Aarhus
CAP-BRAIN
Sun Yat-sen University
IORT_BRAINM1
Institut Català d'Oncologia
ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
Fudan University
The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment
Shanghai Henlius Biotech
Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Sun Yat-sen University
Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.
Seoul St. Mary's Hospital
HiSparCK
Ottawa Hospital Research Institute
Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC
Hubei Cancer Hospital
Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Sun Yat-sen University
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases
Soroka University Medical Center
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
Sun Yat-sen University
TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC
Chongqing University Cancer Hospital
A-Plus
National Taiwan University Hospital
Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases
National Taiwan University Hospital
Central Nervous System(CNS) Efficacy of Dacomitinib
Samsung Medical Center
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
First People's Hospital of Hangzhou
Study of DC Vaccination Against Glioblastoma
Huashan Hospital
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Betta Pharmaceuticals Co., Ltd.
HER2BAT
Second Affiliated Hospital, School of Medicine, Zhejiang University
High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
Samsung Medical Center
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer
Sun Yat-sen University
BRATR
Second Affiliated Hospital of Nanchang University
SRS Sequential Sindilimab in Brain Metastasis of NSLSC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
FSRT in Breast Cancer Patients With Brain Metastases
Fudan University
Pyrotinib
ChineseAMS
GBM
Immunitor LLC
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Guangzhou Medical University
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
Betta Pharmaceuticals Co., Ltd.
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
BRILLIANT
National Taiwan University Hospital
Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer
Shanxi Province Cancer Hospital
KROG17-06
Samsung Medical Center
18F-FET PET in Childhood Brain Tumours
Charite University, Berlin, Germany
Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)
NovoCure Ltd.
HIPPO-SPARE 01
University of Erlangen-Nürnberg Medical School
A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases
Sun Yat-sen University
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
China Medical University Hospital
TRACTS
Wu Jieping Medical Foundation
High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Shandong Cancer Hospital and Institute
Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents
Seoul National University Hospital
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
National Cancer Institute (NCI)